Mechanisms of platelet-activating factor-induced lipid body formation: Requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1515-1525

  Bozza, Patricia T ^a   Payne, Jennifer L ^a   Goulet, Jennifer L ^b   Weller, Peter F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; APAFANT; ARACHIDONATE 5 LIPOXYGENASE; CALCIMYCIN; CHELERYTHRINE; COMPLEMENT COMPONENT C5A; CYCLOHEXIMIDE; DACTINOMYCIN; DIETHYLCARBAMAZINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GUANINE NUCLEOTIDE BINDING PROTEIN; ICOSANOID; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; PERTUSSIS TOXIN; PHOSPHOLIPASE C INHIBITOR; PROSTAGLANDIN E2; PROTEIN KINASE C INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; STAUROSPORINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; ZILEUTON;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; INFLAMMATION; LEUKOCYTE COUNT; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; THROMBOCYTE ACTIVATION;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CELL COMPARTMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEINS; HUMANS; INCLUSION BODIES; LIPID METABOLISM; LIPOXYGENASE INHIBITORS; MICE; MICE, KNOCKOUT; NEUTROPHILS; PHOSPHOLIPASE C; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 0029994949     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1515     Document Type: Article

References (39)

1. Samuelsson, B., S.E. Dahlen, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects Science (Wash. DC). 237:1171-1176.
2. Serhan, C.N. 1994. Eicosanoids in leukocyte function. Curr. Opin Hematol. 1:69-77.
3. Coimbra, A., and A. Lopes-Vaz. 1971. The presence of lipid droplets and the absence of stable sudanophilia in osmiumfixed human leukocytes. J. Histochem. Cytochem. 19:551-557.
4. Triggiani, M., A. Oriente, M.C. Seeds, D.A. Bass, G. Marone, and F.H. Chilton. 1995. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J. Exp. Med. 182:1181-1190.
5. Robinson, J.M., M.L. Karnovsky, and M.J. Karnovsky. 1982. Glycogen accumulation in polymorphonuclear leukocytes, and other intracellular alterations that occur during inflammation. J. Cell Biol. 95:933-942.
6. Weller, P.F., S.J. Ackerman, A. Nicholson-Weller, and A.M. Dvorak. 1989. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am. J. Pathol. 135:947-959.
7. Weller, P.F., R.A. Monahan-Earley, H.F. Dvorak, and A.M. Dvorak. 1991. Cytoplasmic lipid bodies of human eosinophils: subcellular isolation and analysis of arachidonate incorporation. Am. J. Pathol. 138:141-148.
8. Dvorak, A.M., E. Morgan, R.P. Schleimer, S.W. Ryeom, L M. Lichtenstein, and P.F. Weller. 1992 Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to nonmembrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes and neutropbils. J. Histochem. Cytochem. 40:759-769.
9. Dvorak, A.M., R.P. Schleimer, A.M. Dvorak, L.M. Lichtenstein, and P.F. Weller. 1992. Human lung mast cell and alveolar macrophage cytoplasmic lipid bodies contain arachidonic acid and prostaglandin endoperoxide synthase (cyclooxygenase), the substrate and enzyme necessary for prostaglandin production. Int. Arch. Allergy Appl. Immunol. 99:208-217.
10. Dvorak, A.M., E. Morgan, D.M. Tzizik, and P.F. Weller. 1994. Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and murine 3T3 fibroblasts. Int. Arch. Allergy Immunol. 105:245-250.
11. Goulet, J.L., J.N. Snouwaert, A.M. Latour, T.M. Coffman, and B.H. Koller. 1994. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA. 92: 12852-12856.
12. Kew, R.R., C.M. Grimaldi, M.B. Furie, and H.B. Fleit. 1992. Human neutrophil FcγRIIIB and formyl peptide receptors are functionally linked during formyl-methionylleucyl-phenylalanine-induced chemotaxis. J. Immunol. 149: 989-997.
13. Miller, D.K., J.W. Gillard, P.J. Vickers, S. Sadowski, C. Leveille, J.A. Mancim, P. Charleson, R.A. Dixon, A.W. Ford Hutchinson, R. Fortin, et al. 1990. Identification and isola tion of a membrane protein necessary for leukotriene production. Nature (Lond.). 343:278-281.
14. Carter, G.W., P.R. Young, D.H. Albert, J. Bouska, R. Dyer, R.L. Bell, J.B. Summers, and D.W. Brooks. 1991. 5-lipoxygenase inhibitory activity of zileuton. J. Phannacol. Exp Ther. 256:929-937.
15. 4 plays a critical role in the progression of collagen-induced arthritis. Proc. Natl. Acad. Sci. USA. 92:517-521.
16. Verghese, M.W., L. Charles, L. Jakoi, S.B. Dillon, and R. Snyderman. 1987. Role of a guanine nucleotide regulatory protein m the activation of phospholipase C by different chemoattractants. J. Immunol. 138:4374-4380.
17. 2-mediated signalling in neutrophils. Biochim. Biophys. Acta. 1113:135-160.
18. 2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J. Biol. Chem. 267:13830-13835.
19. Shutze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke. 1992. TNF activates NF-KB by phosphatidylcholme-specific phospholipase-C-induced "acidic" sphingomyelin breakdown. Cell. 71:765-776.
20. 3H]-arachidonic acid incorporated by mast cells, macrophages and other cell types. In Prostaglandins, Leukotrienes, and Lipoxms. J.M. Bailey, editor. Plenum Publishing Corp., New York. 221-239.
21. Weller, P.F., S.W. Ryeom, S.T. Picard, S.J. Ackerman, and A.M. Dvorak. 1991. Cytoplasmic lipid bodies of neutrophils: formation induced by cis-unsaturated fatty acids and mediated by protein kinase C. J. Cell Biol. 113:137-146.
22. Braquet, P., L. Touqui, T. Shen, and B.B. Vargaftig. 1987. Perspectives in platelet-activating factor research. Phannacol. Rev. 39:2-97.
23. Murphy, P.M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633.
24. Chen, X.-S., J.R. Sheller, E.N. Johnson, and C.D. Funk. 1994. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature (Lond.). 372:179-182.
25. Henderson, W.R., Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684-697.
26. Rossi, A.G., and J.T. O'Flaherty. 1991. Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor. Lipids. 26:1184-1188.
27. Serhan, C.N. 1995. Leukocyte transmigration, chemotaxis, and oxygenated derivatives of arachidonic acid: when is chirality important? Am. J. Respir Cell Mol. Biol. 12:251-253.
28. Rossi, A.G., M.J. Thomas, and J.T. O'Flaherty. 1988. Stereospecific bioactions of 5-hydroxyicosatetraenoate. FEBS (Fed. Eur. Biochem. Soc.) Lett. 240:163-166.
29. O'Flaherty, J.T., and A.G. Rossi. 1993. 5-hydroxyicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism. J. Biol. Chem. 268:14708-14714.
30. Powell, W.S., F. Gravelle, and S. Gravel. 1992. Metabolism of 5(S)-hydroxy-6,8,11,14-eicosatetraenoic acid and other 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes. J. Biol. Chem. 267: 19233-19241.
31. 4 receptor. J. Biol. Chem. 268:9280-9286.
32. Stenson, W.F., and C.W. Parker. 1979. Metabolism of arachidonic acid in ionophore-stimulated neutrophils. J. Clin. Invest. 64:1457-1465.
33. Shukla, S.D. 1991. Inositol phospholipid turnover in PAF transmembrane signalling. Lipids. 26:1028-1033.
34. Clapham, D.E. 1995. Calcium signaling. Cell. 80:259-268.
35. Ruegg, U.T., and G.M. Burgess. 1989. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol. Sci. 10:218-220.
36. Herbert, J.M., J.M. Augereau, J. Gleye, and J.P. Maffrand. 1990. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172:993-999.
37. 2, 5-lipoxygenase and acetyltransferase activation in human neutrophils. Biochim. Biophys. Acta. 1991:178-184.
38. 1 macrophage-like cells for enhanced arachidonic acid metabolism. J. Biol. Chem. 265:8658-8664.
39. Stewart, A.G., P.N. Dubbin, T. Harris, and G.J. Dusting. 1990. Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc. Natl. Acad. Sci. USA. 87: 3215-3219.